Sciety’s portfolio company Capitainer secures SEK 30 million investment from We Venture Capital, part of the Werfen Group
Sciety’s portfolio company Capitainer, a Swedish medtech company that develops intelligent solutions for self-sampling of blood and plasma, has received a SEK 30 million investment from We Venture Capital, the venture capital arm of the globally renowned Werfen Group. This strategic investment marks a milestone in Capitainer's journey towards becoming the leading provider of self-sampling solutions.We Venture Capital, the venture capital arm of Werfen Group, specialises in empowering innovative companies at the forefront of diagnostic technology. This investment aligns with their mission of